相关实验视频
Updated: May 5, 2026

06:11
A High-throughput Shigella-specific Bactericidal Assay
Published on: February 27, 2019
11.7K
经过BECC工程的活减弱的Shigella候选疫苗在小鼠中显示出降低的内毒性与强大的免疫性
Matthew E Sherman1, Jane Michalski1,2, Sayan Das1
1University of Maryland-Baltimore, Department of Microbial Pathogenesis, Baltimore, MD 21201 USA.
Research square
|July 1, 2024
概括
研究人员使用细菌酶组合化学 (BECC) 设计了活衰减的Shigella疫苗. 这种修改降低了内毒性,同时保持了免疫性,为更安全的西格拉疫苗提供了有前途的途径.
科学领域:
- 微生物学 微生物学
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
背景情况:
- 滋格拉菌感染导致全球严重的疾病,特别是在儿童中.
- 由于抗生素耐药性的增加,现有的治疗选择是有限的.
- 目前的Shigella疫苗候选人具有炎症性脂质A结构,导致内毒性.
研究的目的:
- 为了设计更安全的活体减弱的Shigella疫苗菌株.
- 为了减少Shigella脂多糖 (LPS) 的炎症性质.
- 评估改性疫苗菌株的安全性和免疫性.
主要方法:
- 使用细菌酶组合化学 (BECC) 来修改脂质A结构.
- 异位表达的脂质A在Shigella菌株中的修饰酶.
- 评估LPS诱导的TLR4信号在体外和体内的内毒性影响.
主要成果:
- 脂质A的脱酸化降低了LPS诱导的TLR4信号传递和体内内毒性.
- 经BECC修改的菌株保留了父母的入侵性和免疫性特征.
- 工程疫苗表现出减少不良内毒性.
结论:
- 细菌酶组合化学 (BECC) 对于设计更安全的西格拉疫苗是有效的.
- 向脂质A的修改可以减轻LPS诱导的炎症.
- 经过BECC工程设计的活体减弱的Shigella疫苗代表了一个有前途的开发方法.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Bacterial Gastroenteritis
88
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88

